Asthma diagnosis and treatment: Filling in the information gaps

Journal of Allergy and Clinical Immunology

Volumn 128, Issue 4, 2011, Pages 740-750

  Busse, William W ^a  

^a University of Wisconsin Health   (United States)

Author keywords

Asthma; asthma diagnosis; asthma heterogeneity; asthma management

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BIOLOGICAL MARKER; CHLORIDE CHANNEL REGULATOR 1; CLADE B; CLARITHROMYCIN; CORTICOSTEROID; FLUTICASONE; FRACTION OF EXHALED NITRIC OXIDE; INTERLEUKIN 13; INTERLEUKIN 5; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MANNITOL; MEPOLIZUMAB; METHACHOLINE; NITRIC OXIDE; OMALIZUMAB; PLACEBO; PREDNISONE; SALMETEROL; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

AIRWAY INFLAMMATION; AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; BRONCHIAL HYPERRESPONSIVENESS; BRONCHUS HYPERREACTIVITY; CLINICAL EFFECTIVENESS; DIAGNOSTIC PROCEDURE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG DOSE COMPARISON; DRUG DOSE ESCALATION; DRUG MEGADOSE; EOSINOPHIL; EPITHELIUM CELL; FORCED EXPIRATORY VOLUME; GENE EXPRESSION; HEALTH CARE; HUMAN; INFLAMMATION; INHALATION TEST; LOW DRUG DOSE; LUNG FUNCTION; MORBIDITY; PATIENT CARE; PHENOTYPE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SPIROMETRY; SPUTUM ANALYSIS; STIMULUS; SYMPTOM;

ASTHMA; DIAGNOSIS, DIFFERENTIAL; HUMANS; SEVERITY OF ILLNESS INDEX;

EID: 80053567423     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2011.08.014     Document Type: Article

References (83)

1. National Asthma Education and Prevention Program Expert panel report: guidelines for the diagnosis and management of asthma 1991 National Institutes of Health Bethesda Bethesda Publication no. 91-3642
2. National Asthma Education and Prevention Program Expert panel report 3: guidelines for the diagnosis and management of asthma 2007 National Institutes of Health Bethesda publication no. 07-4051
3. S.J. Szefler Advancing asthma care: the glass is only half full! J Allergy Clin Immunol 128 2011 485 494
4. W.C. Moore, E.R. Bleecker, D. Curran-Everett, S.C. Erzurum, B.T. Ameredes, and L. Bacharier Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program J Allergy Clin Immunol 119 2007 405 413 (Pubitemid 46210080)
5. P. Haldar, I.D. Pavord, D.E. Shaw, M.A. Berry, M. Thomas, and C.E. Brightling Cluster analysis and clinical asthma phenotypes Am J Respir Crit Care Med 178 2008 218 224
6. S.E. Wenzel Asthma: defining of the persistent adult phenotypes Lancet 368 2006 804 813 (Pubitemid 44279058)
7. A plea to abandon asthma as a disease concept Lancet 368 2006 705
8. W.C. Moore, D.A. Meyers, S.E. Wenzel, W.G. Teague, H. Li, and X. Li Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program Am J Respir Crit Care Med 181 2010 315 323
9. American Thoracic Society Lung function testing: selection of reference values and interpretative strategies Am Rev Respir Dis 144 1991 1202 1218
10. A. Schneider, L. Gindner, L. Tilemann, T. Schermer, G.J. Dinant, and F.J. Meyer Diagnostic accuracy of spirometry in primary care BMC Pulm Med 9 2009 31
11. S.J. Szefler, S. Weiss, J. Tonascia, and Childhood Asthma Management Program Research G Long-term effects of budesonide or nedocromil in children with asthma N Engl J Med 343 2000 1054 1063
12. D.W. Cockcroft, and B.E. Davis Mechanisms of airway hyperresponsiveness J Allergy Clin Immunol 118 2006 551 559 (Pubitemid 44301418)
13. W.W. Busse The relationship of airway hyperresponsiveness and airway inflammation: Airway hyperresponsiveness in asthma: its measurement and clinical significance Chest 138 suppl 2010 4S 10S
14. J.K. Sont, L.N. Willems, E.H. Bel, J.H. Van Krieken, J.P. Vandenbroucke, and P.J. Sterk Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group Am J Respir Crit Care Med 159 1999 1043 1051 (Pubitemid 29202534)
15. P.D. Pare, B.E. McParland, and C.Y. Seow Structural basis for exaggerated airway narrowing Can J Physiol Pharmacol 85 2007 653 658 (Pubitemid 350033262)
16. P.D. Pare Airway hyperresponsiveness in asthma: geometry is not everything! Am J Respir Crit Care Med 168 2003 913 914 (Pubitemid 37267169)
17. S.D. Anderson, B. Charlton, J.M. Weiler, S. Nichols, S.L. Spector, and D.S. Pearlman Comparison of mannitol and methacholine to predict exercise-induced bronchoconstriction and a clinical diagnosis of asthma Respir Res 10 2009 4
18. S.D. Anderson Indirect challenge tests: Airway hyperresponsiveness in asthma: its measurement and clinical significance Chest 138 suppl 2010 25S 30S
19. H. Majid, and C. Kao Utility of exhaled nitric oxide in the diagnosis and management of asthma Curr Opin Pulm Med 16 2010 42 47
20. A.D. Smith, J.O. Cowan, K.P. Brassett, S. Filsell, C. McLachlan, and G. Monti-Sheehan Exhaled nitric oxide: a predictor of steroid response Am J Respir Crit Care Med 172 2005 453 459 (Pubitemid 41117391)
21. H.L. Petsky, C.J. Cates, A. Li, J.A. Kynaston, C. Turner, and A.B. Chang Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults Cochrane Database Syst Rev 2 2009 CD006340
22. A.D. Smith, J.O. Cowan, K.P. Brassett, G.P. Herbison, and D.R. Taylor Use of exhaled nitric oxide measurements to guide treatment in chronic asthma N Engl J Med 352 2005 2163 2173
23. D.E. Shaw, M.A. Berry, M. Thomas, R.H. Green, C.E. Brightling, and A.J. Wardlaw The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial Am J Respir Crit Care Med 176 2007 231 237 (Pubitemid 47195872)
24. S.J. Szefler, H. Mitchell, C.A. Sorkness, P.J. Gergen, G.T. O'Connor, and W.J. Morgan Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial Lancet 372 2008 1065 1072
25. R.A. Dweik, R.L. Sorkness, S. Wenzel, J. Hammel, D. Curran-Everett, and S.A. Comhair Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma Am J Respir Crit Care Med 181 2010 1033 1041
26. E. Pizzichini, M.M. Pizzichini, A. Efthimiadis, S. Evans, M.M. Morris, and D. Squillace Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements Am J Respir Crit Care Med 154 1996 308 317 (Pubitemid 26269096)
27. J.V. Fahy, H.A. Boushey, S.C. Lazarus, E.A. Mauger, R.M. Cherniack, and V.M. Chinchilli Safety and reproducibility of sputum induction in asthmatic subjects in a multicenter study Am J Respir Crit Care Med 163 2001 1470 1475 (Pubitemid 32506618)
28. F.E. Hargreave, and P. Nair Point: Is measuring sputum eosinophils useful in the management of severe asthma? Yes Chest 139 2011 1270 1273
29. A. Deykin, S.C. Lazarus, J.V. Fahy, M.E. Wechsler, H.A. Boushey, and V.M. Chinchilli Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids J Allergy Clin Immunol 115 2005 720 727 (Pubitemid 40460845)
30. R.H. Green, C.E. Brightling, S. McKenna, B. Hargadon, D. Parker, and P. Bradding Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial Lancet 360 2002 1715 1721 (Pubitemid 35447900)
31. P. Haldar, C.E. Brightling, B. Hargadon, S. Gupta, W. Monteiro, and A. Sousa Mepolizumab and exacerbations of refractory eosinophilic asthma N Engl J Med 360 2009 973 984
32. P. Nair, M.M. Pizzichini, M. Kjarsgaard, M.D. Inman, A. Efthimiadis, and E. Pizzichini Mepolizumab for prednisone-dependent asthma with sputum eosinophilia N Engl J Med 360 2009 985 993
33. P.G. Woodruff, B. Modrek, D.F. Choy, G. Jia, A.R. Abbas, and A. Ellwanger T-helper type 2-driven inflammation defines major subphenotypes of asthma Am J Respir Crit Care Med 180 2009 388 395
34. J. Corren, R.F. Lemanske Jr., N.A. Hanania, P.E. Korenblat, M.V. Parsey, and J.R. Arron Lebrikizumab treatment in adults with asthma N Engl J Med 2011 [Epub ahead of print]
35. A.L. Innes, K.W. McGrath, R.H. Dougherty, C.E. McCulloch, P.G. Woodruff, and M.A. Seibold The H antigen at epithelial surfaces is associated with susceptibility to asthma exacerbation Am J Respir Crit Care Med 183 2011 189 194
36. S.T. Holgate Pathophysiology of asthma: what has our current understanding taught us about new therapeutic approaches? J Allergy Clin Immunol 128 2011 495 505
37. B.A. Chowdhury, and G. Dal Pan The FDA and safe use of long-acting beta-agonists in the treatment of asthma N Engl J Med 362 2010 1169 1171
38. B.A. Chowdhury, S.M. Seymour, and M.S. Levenson Assessing the safety of adding LABAs to inhaled corticosteroids for treating asthma N Engl J Med 364 2011 2473 2475
39. R.F. Lemanske Jr., D.T. Mauger, C.A. Sorkness, D.J. Jackson, S.J. Boehmer, and F.D. Martinez Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids N Engl J Med 362 2010 975 985
40. A. Thomas, R.F. Lemanske Jr., and D.J. Jackson Approaches to stepping-up and stepping-down care in asthma J Allergy Clin Immunol 2011 [Epub ahead of print]
41. S.J. Fowler, G.P. Currie, and B.J. Lipworth Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone J Allergy Clin Immunol 109 2002 929 935 (Pubitemid 34634301)
42. L.B. Bacharier "Step-down" therapy for asthma: why, when, and how? J Allergy Clin Immunol 109 2002 916 919
43. B.P. Yawn, P.C. Wollan, S.L. Bertram, D. Lowe, J.H. Butterfield, and D. Bonde Asthma treatment in a population-based cohort: putting step-up and step-down treatment changes in context Mayo Clinic Proc 82 2007 414 421 (Pubitemid 46543464)
44. A. Foresi, B. Mastropasqua, A. Chetta, R. D'Ippolito, R. Testi, and D. Olivieri Step-down compared to fixed-dose treatment with inhaled fluticasone propionate in asthma Chest 127 2005 117 124 (Pubitemid 41724564)
45. E.D. Bateman, L. Jacques, C. Goldfrad, T. Atienza, T. Mihaescu, and M. Duggan Asthma control can be maintained when fluticasone propionate/salmeterol in a single inhaler is stepped down J Allergy Clin Immunol 117 2006 563 570 (Pubitemid 43340219)
46. P. Godard, P. Greillier, B. Pigearias, G. Nachbaur, J.L. Desfougeres, and V. Attali Maintaining asthma control in persistent asthma: comparison of three strategies in a 6-month double-blind randomised study Respir Med 102 2008 1124 1131
47. S.M. Koenig, N. Ostrom, D. Pearlman, K. Waitkus-Edwards, S. Yancey, and B.A. Prillaman Deterioration in asthma control when subjects receiving fluticasone propionate/salmeterol 100/50 mcg Diskus are "stepped-down" J Asthma 45 2008 681 687
48. E.D. Bateman, H.A. Boushey, J. Bousquet, W.W. Busse, T.J. Clark, and R.A. Pauwels Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study Am J Respir Crit Care Med 170 2004 836 844 (Pubitemid 39346477)
49. W.W. Busse, R.F. Lemanske Jr., and J.E. Gern Role of viral respiratory infections in asthma and asthma exacerbations Lancet 376 2010 826 834
50. H.K. Reddel, D.R. Taylor, E.D. Bateman, L.P. Boulet, H.A. Boushey, and W.W. Busse An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice Am J Respir Crit Care Med 180 2009 59 99
51. T.W. Harrison, J. Oborne, S. Newton, and A.E. Tattersfield Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial Lancet 363 2004 271 275 (Pubitemid 38142409)
52. J.M. FitzGerald, A. Becker, M.R. Sears, S. Mink, K. Chung, and J. Lee Doubling the dose of budesonide vs maintenance therapy in asthma exacerbations Thorax 59 2004 550 556 (Pubitemid 38901511)
53. R.A. Pauwels, C.G. Lofdahl, D.S. Postma, A.E. Tattersfield, P. O'Byrne, and P.J. Barnes Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group N Engl J Med 337 1997 1405 1411
54. H.W. Kelly Inhaled corticosteroid dosing: double for nothing? J Allergy Clin Immunol 128 2011 278 281 e2
55. P.M. O'Byrne, H. Bisgaard, P.P. Godard, M. Pistolesi, M. Palmqvist, and Y. Zhu Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma Am J Respir Crit Care Med 171 2005 129 136 (Pubitemid 40105411)
56. W.W. Busse, W.J. Morgan, P.J. Gergen, H.E. Mitchell, J.E. Gern, and A.H. Liu Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children N Engl J Med 364 2011 1005 1015
57. W. Busse, J. Corren, B.Q. Lanier, M. McAlary, A. Fowler-Taylor, and G.D. Cioppa Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma J Allergy Clin Immunol 108 2001 184 190 (Pubitemid 32735398)
58. S.T. Holgate, R. Djukanovic, T. Casale, and J. Bousquet Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy Clin Exp Allergy 35 2005 408 416 (Pubitemid 40577231)
59. M. Humbert, R. Beasley, J. Ayres, R. Slavin, J. Hebert, and J. Bousquet Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE Allergy 60 2005 309 316 (Pubitemid 40293346)
60. B. Lanier, T. Bridges, M. Kulus, A.F. Taylor, I. Berhane, and C.F. Vidaurre Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma J Allergy Clin Immunol 124 2009 1210 1216
61. N.W. Johnston, S.L. Johnston, G.R. Norman, J. Dai, and M.R. Sears The September epidemic of asthma hospitalization: school children as disease vectors J Allergy Clin Immunol 117 2006 557 562 (Pubitemid 43340218)
62. National Asthma Education and Prevention Program Guidelines for the diagnosis and management of asthma: expert panel report 2 1997 National Institutes of Health Bethesda Publication no. 97-4051
63. A.L. Kozyrskyj, M.E. Dahl, W.J. Ungar, A.B. Becker, and B.J. Law Antibiotic treatment of wheezing in children with asthma: what is the practice? Pediatrics 117 2006 e1104 e1110
64. S.G. Vanderweil, C.L. Tsai, A.J. Pelletier, J.A. Espinola, A.F. Sullivan, and D. Blumenthal Inappropriate use of antibiotics for acute asthma in United States emergency departments Acad Emerg Med 15 2008 736 743
65. M. Kraft, G.H. Cassell, J. Pak, and R.J. Martin Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin Chest 121 2002 1782 1788 (Pubitemid 34634396)
66. P.N. Black, F. Blasi, C.R. Jenkins, R. Scicchitano, G.D. Mills, and A.R. Rubinfeld Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae Am J Respir Crit Care Med 164 2001 536 541 (Pubitemid 32801652)
67. H. Bisgaard, M.N. Hermansen, K. Bonnelykke, J. Stokholm, F. Baty, and N.L. Skytt Association of bacteria and viruses with wheezy episodes in young children: prospective birth cohort study BMJ 341 2010 c4978
68. Y.S. Lopez-Boado, and B.K. Rubin Macrolides as immunomodulatory medications for the therapy of chronic lung diseases Curr Opin Pharmacol 8 2008 286 291
69. T. Suzuki, M. Yamaya, K. Sekizawa, M. Hosoda, N. Yamada, and S. Ishizuka Erythromycin inhibits rhinovirus infection in cultured human tracheal epithelial cells Am J Respir Crit Care Med 165 2002 1113 1118 (Pubitemid 34415820)
70. V. Gielen, S.L. Johnston, and M.R. Edwards Azithromycin induces anti-viral responses in bronchial epithelial cells Eur Respir J 36 2010 646 654
71. J.V. Fahy, K.W. Kim, J. Liu, and H.A. Boushey Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation J Allergy Clin Immunol 95 1995 843 852
72. C. Lamblin, P. Gosset, I. Tillie-Leblond, F. Saulnier, C.H. Marquette, and B. Wallaert Bronchial neutrophilia in patients with noninfectious status asthmaticus Am J Respir Crit Care Med 157 1998 394 402 (Pubitemid 28090526)
73. C.L. Ordonez, T.E. Shaughnessy, M.A. Matthay, and J.V. Fahy Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma: Clinical and biologic significance Am J Respir Crit Care Med 161 2000 1185 1190 (Pubitemid 30243828)
74. E.R. Sutherland, T.S. King, N. Icitovic, B.T. Ameredes, E. Bleecker, and H.A. Boushey A trial of clarithromycin for the treatment of suboptimally controlled asthma J Allergy Clin Immunol 126 2010 747 753
75. S.B. Barnett, and T.A. Nurmagambetov Costs of asthma in the United States: 2002-2007 J Allergy Clin Immunol 127 2011 145 152
76. T. Haselkorn, J.E. Fish, R.S. Zeiger, S.J. Szefler, D.P. Miller, and B.E. Chipps Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study J Allergy Clin Immunol 124 2009 895 902 e1-4
77. S.E. Wenzel, and W.W. Busse Severe asthma: lessons from the Severe Asthma Research Program J Allergy Clin Immunol 119 2007 14 23
78. S.T. Holgate, J. Holloway, S. Wilson, P.H. Howarth, H.M. Haitchi, and S. Babu Understanding the pathophysiology of severe asthma to generate new therapeutic opportunities J Allergy Clin Immunol 117 2006 496 507 (Pubitemid 43340211)
79. W.C. Moore, and S.P. Peters Severe asthma: an overview J Allergy Clin Immunol 117 2006 487 494
80. N.A. Hanania, O. Alpan, D.L. Hamilos, J.J. Condemi, I. Reyes-Rivera, and J. Zhu Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial Ann Intern Med 154 2011 573 582
81. P.A. Wark, S.L. Johnston, F. Bucchieri, R. Powell, S. Puddicombe, and V. Laza-Stanca Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus J Exp Med 201 2005 937 947 (Pubitemid 40524463)
82. M. Contoli, S.D. Message, V. Laza-Stanca, M.R. Edwards, P.A. Wark, and N.W. Bartlett Role of deficient type III interferon-lambda production in asthma exacerbations Nat Med 12 2006 1023 1026 (Pubitemid 44353382)
83. S.D. Message, V. Laza-Stanca, P. Mallia, H.L. Parker, J. Zhu, and T. Kebadze Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production Proc Natl Acad Sci U S A 105 2008 13562 13567